WHO guideline on country pharmaceutical pricing policies PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download WHO guideline on country pharmaceutical pricing policies PDF full book. Access full book title WHO guideline on country pharmaceutical pricing policies by . Download full books in PDF and EPUB format.
Author:
Publisher: World Health Organization
ISBN: 9240011870
Category : Business & Economics
Languages : en
Pages : 70
Get Book Here
Book Description
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
Author:
Publisher: World Health Organization
ISBN: 9240011870
Category : Business & Economics
Languages : en
Pages : 70
Get Book Here
Book Description
In recent years, high prices of pharmaceutical products have posed challenges in high- and low-income countries alike. In many instances, high prices of pharmaceutical products have led to significant financial hardship for individuals and negatively impacted on healthcare systems' ability to provide population-wide access to essential medicines. Pharmaceutical pricing policies need to be carefully planned, carried out, and regularly checked and revised according to changing conditions. Strong, well-thought-out policies can guide well-informed and balanced decisions to achieve affordable access to essential health products. This guideline replaces the 2015 WHO guideline on country pharmaceutical pricing policies, revised to reflect the growing body of literature since the last evidence review in 2010. This update also recognizes country experiences in managing the prices of pharmaceutical products.
Author: National Academies of Sciences, Engineering, and Medicine
Publisher: National Academies Press
ISBN: 0309468086
Category : Medical
Languages : en
Pages : 235
Get Book Here
Book Description
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author: Robin Feldman
Publisher: Cambridge University Press
ISBN: 1108659500
Category : Law
Languages : en
Pages : 201
Get Book Here
Book Description
In the warped world of prescription drug pricing, generic drugs can cost more than branded ones, old drugs can be relaunched at astronomical prices, and low-cost options are shut out of the market. In Drugs, Money and Secret Handshakes, Robin Feldman shines a light into the dark corners of the pharmaceutical industry to expose a web of shadowy deals in which higher-priced drugs receive favorable treatment and patients are channeled toward the most expensive medicines. At the center of this web are the highly secretive middle players who establish coverage levels for patients and negotiate with drug companies. By offering lucrative payments to these middle players (as well as to doctors and hospitals), drug companies ensure that inexpensive drugs never gain traction. This system of perverse incentives has delivered the kind of exorbitant drug prices - and profits - that everyone loves except for those who pay the bills.
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 390
Get Book Here
Book Description
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Prices
Languages : en
Pages : 1602
Get Book Here
Book Description
Author: Steven C. Jensen
Publisher: Elsevier Health Sciences
ISBN: 0323277071
Category : Medical
Languages : en
Pages : 208
Get Book Here
Book Description
This text is a complete resource for all the imaging technologies, not just plain film radiography. It provides introductory material on pharmacological nomenclature, drug classifications, pharmacokinetics, and drugs used in imaging. It also offers comprehensive coverage of diagnostic contrast agents, along with drug administration procedures, emergency responses to drug reactions, and legal and ethical aspects of medication administration. - Objectives and Key Terms open each chapter. - Learning exercises include true/false, fill-in-the-blank, multiple-choice, and short-answer questions at the end of each chapter, with answers at the end of the book. - Did You Know? boxes offer interesting tidbits of historical or current pharmacology information, connecting the book's drug content to everyday situations. - Clinical Alert icons point out possible adverse reactions and toxic effects. - Discussion of pharmacodynamics and drug classifications focuses on radiopaque contrast media used in imaging procedures, using clearly written text and useful tables. - Pharmacokinetics coverage describes how drugs are absorbed, metabolized, distributed, and eliminated. - Complete coverage of emergency procedures in response to adverse reactions to contrast media includes crash cart procedures and drugs used to treat cardiac and/or respiratory arrest and how to administer them appropriately. - Updates on all contrast agents. - New information on the use of contrast agents in ultrasound. - New Drug Classifications chapter. - New chapter on drug-related emergencies includes case studies. - Evolve Resources for instructors include a 220-question test bank and an electronic image collection.
Author: United States. Congress. Senate. Committee on the Judiciary. Subcommittee on Antitrust and Monopoly
Publisher:
ISBN:
Category : Prices
Languages : en
Pages : 1210
Get Book Here
Book Description
Author: Rebecca White
Publisher: Pharmaceutical Press
ISBN: 0857111620
Category : Medical
Languages : en
Pages : 753
Get Book Here
Book Description
With over 400 drug monographs, this book covers the technical, practical and legal aspects that you should consider before prescribing or administering drugs via enteral feeding tubes.
Author: United States. Interagency Committee on New Therapies for Pain and Discomfort
Publisher:
ISBN:
Category : Hospice care
Languages : en
Pages : 272
Get Book Here
Book Description
Author: Peter J. Neumann
Publisher: Oxford University Press
ISBN: 0190492937
Category : Business & Economics
Languages : en
Pages : 537
Get Book Here
Book Description
CEAs (cost-effectiveness analyses) are used by decision makers in the health sector to make enlightened evaluations and this book provides an in depth look at how to evaluate the evaluator. The book is aimed specifically at Public health specialists.
